Form 4: Align Technology Director Equity Transaction

Director C. Raymond Larkin Jr. acquired 2,326 shares via RSU vesting and was granted 2,448 new RSUs.

Summary

• Director C. Raymond Larkin Jr. exercised 2,326 restricted stock units (RSUs) on May 20, 2026.
• The exercised RSUs vested from a grant originally issued on May 21, 2025.
• Following the transaction, the director holds 27,454 shares of common stock.
• A new grant of 2,448 RSUs was issued to the director on May 20, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director equity compensation with no impact on company operations.

Positives

• Director maintains a significant equity stake of 27,454 shares, aligning interests with shareholders.

Negatives

• None identified.

Risks

• Vesting of new RSU grant is contingent upon the director's continued service through May 20, 2027.

Future Outlook

The director's new RSU grant is scheduled to vest on May 20, 2027, or the date of the next annual meeting, subject to continued service.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of director compensation and equity alignment, common among large-cap medical device companies to ensure board members remain incentivized by long-term stock performance.

Comparison to Industry Standards

• The use of RSU grants for board compensation is standard practice for S&P 500 companies.
• The vesting schedule of one year is consistent with typical director equity retention policies.

Stakeholder Impact

• Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of 2,448 RSUs on May 20, 2027.

Key Dates

Keywords

Align Technology, ALGN, Form 4, Insider Trading, Director Equity, Restricted Stock Units